Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our tirzepatide UK price offers exceptional value for research-grade material with 99% purity. The white powder formulation is available in various vial sizes (5mg, 10mg, 15mg) to meet different research requirements. As a dual agonist, tirzepatide exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity.
The product is supplied in pharmaceutical grade quality with comprehensive analytical documentation. We offer customized packaging solutions including different vial sizes (2mg-50mg range) and private labeling options for bulk orders. The competitive tirzepatide UK price makes this material accessible for various research applications.
For research use only. Not for human consumption. All products are strictly for laboratory research purposes.